Prevention of Obesity and Insulin Resistance – (01-29-04)

Prevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1

Don’t feel bad–I’m new to the concept of PAI-1 being used as a marker for insulin resistance/Syndrome X as well. Research is still ongoing, but PAI-1 is a compound that increases the “stickiness” of platelets and this make be associated with (some think a causative factor in) Syndrome X. We really do need a solid, accurate method to assess presence and degree of insulin resistance. It would be nice if this compound turns out to be our answer.

Diabetes — Abstracts: Ma et al. 53 (2): 336 –

Read entire article here

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: